Related Experiment Videos
Transcriptional control of the RECK metastasis/angiogenesis suppressor gene
Regina Maki Sasahara1, Sheila Maria Brochado, Chiaki Takahashi
1Instituto de Química, Universidade de São Paulo, CP 26077, São Paulo 05513-970, SP, Brazil.
Abstract:
The RECK gene is widely expressed in normal human tissues but is downregulated in tumor cell lines and oncogenically transformed fibroblasts. RECK encodes a membrane-anchored glycoprotein that suppresses tumor invasion and angiogenesis by regulating matrix-metalloproteinases (MMP-2, MMP-9 and MT1-MMP). Understanding of the transcriptional regulation of tumor/metastasis suppressor genes constitutes a potent approach to the molecular basis of malignant transformation. In order to uncover the mechanisms of control of RECK gene expression, the RECK promoter has been cloned and characterized. One of the elements responsible for the Ras-mediated downregulation of mouse RECK gene is the Sp1 site, to which Sp1 and Sp3 factors bind. Other regulatory events, such as DNA methylation of the RECK promoter and histone acetylation/deacetylation have been studied to understand the underlying mechanisms of RECK expression. Understanding of the mechanisms which control RECK gene transcription may lead to the development of new strategies for cancer prevention and treatment.
Insights
The RECK gene, a tumor suppressor, is downregulated in cancer. Researchers identified regulatory elements and epigenetic mechanisms controlling its expression, offering potential new cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- The RECK gene is widely expressed in normal tissues but downregulated in tumors.
- RECK encodes a glycoprotein that suppresses tumor invasion and angiogenesis by regulating matrix metalloproteinases (MMPs).
- Understanding transcriptional regulation of tumor suppressor genes is key to understanding malignant transformation.
Purpose of the Study:
- To uncover the mechanisms controlling RECK gene expression.
- To characterize the RECK promoter and identify regulatory elements.
- To investigate epigenetic modifications affecting RECK expression.
Main Methods:
- Cloning and characterization of the RECK promoter.
- Identification of Sp1 and Sp3 binding sites.
- Analysis of DNA methylation and histone acetylation/deacetylation.
Main Results:
- The Sp1 site in the mouse RECK promoter is involved in Ras-mediated downregulation.
- Sp1 and Sp3 transcription factors bind to this site.
- DNA methylation and histone modifications also influence RECK gene expression.
Conclusions:
- Transcriptional control of the RECK gene involves specific promoter elements and epigenetic mechanisms.
- Understanding these regulatory mechanisms could lead to novel cancer prevention and treatment strategies.
- Further research into RECK gene regulation is warranted for therapeutic development.